Biovalley Group S.p.A. is a Family and Friends Office investing in micro, SMEs and large companies in the BioHighTech, Digital HighTech and Energy HighTech industrial sectors.
Founded by Diego Bravar in 2014 in Trieste, Biovalley Group develops the "Trieste Innovation Hub Model", investing in innovative companies with strong growth potential.
Biotechnology, medical devices, advanced diagnostics and innovative drugs for health.
ICT solutions, artificial intelligence, cloud computing and high-performance digital services.
Energy transition, sustainable technologies and innovative energy solutions.
Biovalley Group examines investment proposals from micro and small-medium enterprises meeting the following requirements.
The company must be incorporated as a limited company (società di capitali).
Operational headquarters in Friuli Venezia Giulia and/or the Alpe Adria area.
Non-negative net result in the last three approved financial statements.
Non-negative difference between production value and costs.
BIG leads the BioHighTech-NET network, a collaboration agreement between companies to develop shared projects and objectives aimed at increasing innovative capacity and competitiveness in international markets.
In 2020, BioHighTechNet 4.0 was established as an independent legal entity.
Discover BioHighTech-NETControlled and/or invested companies in the BioHighTech, Digital HighTech and Energy HighTech sectors.
Automated and compact system for the preparation of patient-specific anticancer drugs: our flagship project.